These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 23163648)
1. Characterization and longitudinal monitoring of melanoma growth in ret-transgenic mice using a single-sequence MRI protocol. Kerl HU; Boll H; Ramacher M; Heilmann M; Groden C; Kramer M; Umansky V; Brockmann MA Exp Dermatol; 2012 Nov; 21(11):837-41. PubMed ID: 23163648 [TBL] [Abstract][Full Text] [Related]
3. Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma. Zhao F; Falk C; Osen W; Kato M; Schadendorf D; Umansky V Clin Cancer Res; 2009 Jul; 15(13):4382-90. PubMed ID: 19549770 [TBL] [Abstract][Full Text] [Related]
4. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma. von Felbert V; Córdoba F; Weissenberger J; Vallan C; Kato M; Nakashima I; Braathen LR; Weis J Am J Pathol; 2005 Mar; 166(3):831-41. PubMed ID: 15743795 [TBL] [Abstract][Full Text] [Related]
6. Ret transgenic mouse model of spontaneous skin melanoma: focus on regulatory T cells. Umansky V; Sevko A Pigment Cell Melanoma Res; 2013 Jul; 26(4):457-63. PubMed ID: 23560814 [TBL] [Abstract][Full Text] [Related]
7. Effect of artesunate on immune cells in ret-transgenic mouse melanoma model. Ramacher M; Umansky V; Efferth T Anticancer Drugs; 2009 Nov; 20(10):910-7. PubMed ID: 19745721 [TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse model for skin malignant melanoma. Kato M; Takahashi M; Akhand AA; Liu W; Dai Y; Shimizu S; Iwamoto T; Suzuki H; Nakashima I Oncogene; 1998 Oct; 17(14):1885-8. PubMed ID: 9778055 [TBL] [Abstract][Full Text] [Related]
9. Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors. Umansky V; Abschuetz O; Osen W; Ramacher M; Zhao F; Kato M; Schadendorf D Cancer Res; 2008 Nov; 68(22):9451-8. PubMed ID: 19010920 [TBL] [Abstract][Full Text] [Related]
10. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. El Khoury D; Destouches D; Lengagne R; Krust B; Hamma-Kourbali Y; Garcette M; Niro S; Kato M; Briand JP; Courty J; Hovanessian AG; Prévost-Blondel A BMC Cancer; 2010 Jun; 10():325. PubMed ID: 20573279 [TBL] [Abstract][Full Text] [Related]
11. Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice. Klein-Szanto AJ; Silvers WK; Mintz B Cancer Res; 1994 Sep; 54(17):4569-72. PubMed ID: 8062242 [TBL] [Abstract][Full Text] [Related]
12. Metastatic cutaneous melanoma promoted by ultraviolet radiation in mice with transgene-initiated low melanoma susceptibility. Kelsall SR; Mintz B Cancer Res; 1998 Sep; 58(18):4061-5. PubMed ID: 9751610 [TBL] [Abstract][Full Text] [Related]
13. A novel mouse model for de novo Melanoma. Kumasaka MY; Yajima I; Hossain K; Iida M; Tsuzuki T; Ohno T; Takahashi M; Yanagisawa M; Kato M Cancer Res; 2010 Jan; 70(1):24-9. PubMed ID: 20048069 [TBL] [Abstract][Full Text] [Related]
14. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence. Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025 [TBL] [Abstract][Full Text] [Related]
15. Lymphadenectomy promotes tumor growth and cancer cell dissemination in the spontaneous RET mouse model of human uveal melanoma. Pin YK; Khoo K; Tham M; Karwai T; Hwee TC; Puaux AL; Phua ML; Kato M; Angeli V; Abastado JP Oncotarget; 2015 Dec; 6(42):44806-18. PubMed ID: 26575174 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal cohort analysis of lethal prostate cancer progression in transgenic mice. Hsu CX; Ross BD; Chrisp CE; Derrow SZ; Charles LG; Pienta KJ; Greenberg NM; Zeng Z; Sanda MG J Urol; 1998 Oct; 160(4):1500-5. PubMed ID: 9751403 [TBL] [Abstract][Full Text] [Related]
17. CXCL10 reduces melanoma proliferation and invasiveness in vitro and in vivo. Antonicelli F; Lorin J; Kurdykowski S; Gangloff SC; Le Naour R; Sallenave JM; Hornebeck W; Grange F; Bernard P Br J Dermatol; 2011 Apr; 164(4):720-8. PubMed ID: 21155750 [TBL] [Abstract][Full Text] [Related]
19. Transgenic mice with pigmented intraocular tumors: tissue of origin and treatment. Syed NA; Windle JJ; Darjatmoko SR; Lokken JM; Steeves RA; Chappell R; Wallow IH; Koop BA; Mangold G; Howes KA; Albert DM Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2800-5. PubMed ID: 9856795 [TBL] [Abstract][Full Text] [Related]
20. BMP-4 down-regulates the expression of Ret in murine melanocyte precursors. Kawakami T; Kumasaka M; Kato M; Mizoguchi M; Soma Y J Dermatol Sci; 2011 Jul; 63(1):66-9. PubMed ID: 21530183 [No Abstract] [Full Text] [Related] [Next] [New Search]